<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03085524</url>
  </required_header>
  <id_info>
    <org_study_id>161402</org_study_id>
    <nct_id>NCT03085524</nct_id>
  </id_info>
  <brief_title>The Impact of Diabetes on REvascularization</brief_title>
  <acronym>TIDE</acronym>
  <official_title>The Impact of Diabetes on REvascularization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HealthCore-NERI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The presence of foot symptoms at rest or tissue necrosis in patients with peripheral artery&#xD;
      disease is a medical urgency and represents a state of critical limb ischemia (CLI) where the&#xD;
      risk of amputation, in the absence of revascularization, is high. No trial conducted to date&#xD;
      in peripheral revascularization has determined the effect of diabetes on mechanism of&#xD;
      revascularization failure. Therefore, this trial represents a unique opportunity to&#xD;
      investigate the mechanisms by which diabetes affects surgical and endovascular&#xD;
      revascularization procedures with the long-term goal of improving outcomes in CLI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral artery disease is a condition defined by marked accumulation of atherosclerotic&#xD;
      plaque below the distal aorta that reduces lower limb arterial perfusion. Blood flow&#xD;
      reductions may be inadequate for exercising limbs and cause ischemic muscle pain, called&#xD;
      intermitted claudication, or, in severe cases, the reduction may be inadequate for basal&#xD;
      metabolism and cause pain at rest, ulceration, or gangrene. The presence of symptoms at rest&#xD;
      or tissue necrosis is a medical urgency and represents a state of critical limb ischemia&#xD;
      (CLI) where the risk of amputation, in the absence of revascularization, is high. The ageing&#xD;
      of the population and the increasing prevalence of diabetes mellitus ensures this population&#xD;
      will continue to grow in the foreseeable future. The impact of diabetes, however, is not&#xD;
      limited to PAD incidence. Diabetic patients represent a particularly vulnerable subset of PAD&#xD;
      patients and have a four-fold risk of CLI compared to non-diabetic patients. Indeed, in&#xD;
      previous studies of CLI, more than half of patients have diabetes. As a result, the&#xD;
      combination of diabetes and PAD accounts for more than half of non-traumatic amputations in&#xD;
      the United States. Diabetic patients often present with foot ulcerations as their first&#xD;
      manifestation of PAD and have challenging anatomy for revascularization. Failed vascular&#xD;
      reconstructions, both endovascular or surgical, often result in additional tissue loss and&#xD;
      transtibial amputations. Despite these challenges, the mechanisms of restenosis and the&#xD;
      impact of diabetes have not been well explored for both types of revascularization in&#xD;
      patients with CLI. The BEST-CLI trial is a multi-center, randomized, comparative&#xD;
      effectiveness trial comparing open surgical bypass therapy to endovascular therapy in CLI&#xD;
      patients with a composite clinical endpoint denoted as Major Adverse Limb Event free survival&#xD;
      (MALE-free survival). However, the BEST-CLI trial does not study the mechanisms by which&#xD;
      revascularization may fail. This proposal will extend the novel clinical work of the BEST-CLI&#xD;
      trial by studying the mechanisms of bypass vein graft and stent failure. The investigators&#xD;
      will adjudicate the mode of revascularization (vein graft or stent) in a central core&#xD;
      laboratory, measure systemic markers of diabetic dysmetabolism including inflammation,&#xD;
      insulin resistance, adverse adipokine expression, poor nutrition, and renal dysfunction, and&#xD;
      begin to study the association of these factors with graft failure. Indeed, no trial&#xD;
      conducted to date in either coronary or peripheral revascularization has determined the&#xD;
      mechanism of revascularization failure, the impact of diabetes, nor the relationship between&#xD;
      conduit patency and clinical outcomes. Therefore, this trial represents a unique opportunity&#xD;
      to investigate the mechanisms by which diabetes affects surgical and endovascular&#xD;
      revascularization procedures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">April 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Limb Event - free survival</measure>
    <time_frame>1 year</time_frame>
    <description>The combination of amputation, surgical revascularization, thrombectomy, thrombosis, interposition graft, or death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Restenosis</measure>
    <time_frame>1 year</time_frame>
    <description>Greater than 50% stenosis as determined by peak systolic velocity ratio of &gt;2.4</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Surgical Bypass</arm_group_label>
    <description>Subjects in the BEST-CLI trial assigned to surgical revascularization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endovascular</arm_group_label>
    <description>Subjects in the BEST-CLI trial assigned to endovascular revascularization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Platelet function testing</intervention_name>
    <description>The investigators will test platelet reactivity at the beginning and midpoint of the first year after revascularization</description>
    <arm_group_label>Endovascular</arm_group_label>
    <arm_group_label>Surgical Bypass</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vascular ultrasonography</intervention_name>
    <description>The investigators will test bypass graft and stent patency at 30 days, 6 months, and 1 year.</description>
    <arm_group_label>Endovascular</arm_group_label>
    <arm_group_label>Surgical Bypass</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Leukocytes&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This ancillary study is an observational study design examining the effects of diabetes&#xD;
        mellitus on restenosis following surgical or endovascular revascularization in CLI&#xD;
        patients. Eligible patients will be screened according to the specified exclusion and&#xD;
        inclusion criteria of the BEST-CLI trial.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female, age 35 years or older&#xD;
&#xD;
          -  Atherosclerotic, infrainguinal PAD&#xD;
&#xD;
          -  CLI, defined as arterial insufficiency with gangrene, non-healing ischemic ulcer, or&#xD;
             rest pain, consistent with Rutherford classes 4-6&#xD;
&#xD;
          -  Candidate for either open or endovascular infrainguinal revascularization as judged by&#xD;
             the treating investigators&#xD;
&#xD;
          -  Adequate inflow into the index femoral artery&#xD;
&#xD;
          -  Adequate popliteal, tibial, or pedal revascularization target&#xD;
&#xD;
          -  Willing to comply with protocol, attend follow-up appointments, complete all study&#xD;
             assessments, and provide informed consent&#xD;
&#xD;
          -  Endovascular revascularization with a stent&#xD;
&#xD;
          -  Surgical revascularization with a vein graft-&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Femoropopliteal disease pattern consistent with TASC IIA&#xD;
&#xD;
          -  Complete occlusion of the iliac artery&#xD;
&#xD;
          -  Aortoiliac occlusive disease or severe common femoral artery disease&#xD;
&#xD;
          -  Presence of a femoral, popliteal or tibial aneurysm of the index limb&#xD;
&#xD;
          -  Life expectancy less than 2 years&#xD;
&#xD;
          -  Deemed excessive risk for surgical bypass&#xD;
&#xD;
          -  A vascular disease prognosis that includes an anticipated above ankle amputation on&#xD;
             index limb within 4 weeks of index procedure&#xD;
&#xD;
          -  Renal dysfunction defined as MDRD eGFR ≤ 30ml/min/173 m2 at the time of screening&#xD;
&#xD;
          -  Currently on dialysis or history of a renal transplant&#xD;
&#xD;
          -  A documented hypercoagulable state&#xD;
&#xD;
          -  Nonatherosclerotic occlusive disease&#xD;
&#xD;
          -  Any prior infrainguinal revascularization&#xD;
&#xD;
          -  Current immuno-suppressive medication, chemotherapy or radiation therapy&#xD;
&#xD;
          -  Absolute contraindication to iodinated contrast&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Long Beach VA Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keck Medical Center of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Francisco VA Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Decatur Memorial Hospital</name>
      <address>
        <city>Decatur</city>
        <state>Illinois</state>
        <zip>62526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Health System: LSU Health Sciences</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Vascular Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Heart - St. Joseph Mercy Health System</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deborah Heart and Lung Center</name>
      <address>
        <city>Browns Mills</city>
        <state>New Jersey</state>
        <zip>08015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rutgers University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico Heart Institute</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westchester Medical Center</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Hospitals</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>28157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Toledo Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Memorial Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Heart and Vascular Institute</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Benaroya Research Institute at Virginia Mason</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gunderson Health System</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin - Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53706</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Boniface General Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4E9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu de Quebec, St-Francois d'Assise Hospital</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1L 3P7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Finland</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>New Zealand</country>
  </removed_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2017</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Joshua Beckman</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The proposed research will include data from approximately 500 subjects enrolled in the BEST-CLI clinical trial. The final dataset will include self-reported demographic, ultrasonographic, and laboratory data from the subjects. The investigators will be collecting identifying information, but the final dataset will be stripped of identifiers prior to release for sharing. Thus, the investigators will make the data and associated documentation available to users only under a data-sharing agreement that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

